Defibrotide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 646 publications
Defibrotide-Responsive Cutaneous Endothelial Injury Following Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.
Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: May 13, 2026
A Comparative Study of Porcine and Ovine Derived Defibrotide: Coagulation Profiles, Molecular Characteristics, and DNA Content.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 23, 2026
Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.
Journal: Current oncology (Toronto, Ont.)
Published: March 01, 2026
Absolute Quantification of Full-Length 16S rRNA Amplicon Sequencing and Metabolomic Profiling of Red-Stipe Disease in Morel Fruiting Bodies.
Journal: Phytopathology
Published: February 26, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.
Journal: European journal of haematology
Published: February 26, 2026
Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With PTCy-Based Prophylaxis.
Journal: Transplantation and cellular therapy
Published: February 13, 2026
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: January 27, 2026
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19.
Journal: Thrombosis and haemostasis
Published: January 23, 2026
Early Initiation of Defibrotide is Associated With Better Survival in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Adults: Experience From Two Canadian Centers.
Journal: Transplantation and cellular therapy
Published: December 23, 2025
Case Report: Short-course defibrotide combined with eculizumab for TA-TMA.
Journal: Frontiers in immunology
Published: December 19, 2025
Inotuzumab ozogamicin-associated sinusoidal obstruction syndrome/veno-occlusive disease diagnosed by transjugular liver biopsy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025
Defibrotide for late-onset sinusoidal obstruction syndrome following umbilical cord blood transplantation: a single-center retrospective study.
Journal: International journal of hematology
Published: November 15, 2025
Last Updated: 06/30/2026